Product information and disease descriptionPlace of product in therapyDisease description
Burden of Type I allergic reactions including anaphylaxis
24 evidence topics · 22 sources
Anaphylm (dibutepinephrine)
Type I allergic reactions including anaphylaxis
- Manufacturer
- Aquestive Therapeutics
- Regulatory submission
- NDA resubmitted September 2026
- Launch
- Not announced
- Last updated